SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-16-000562
Filing Date
2016-11-14
Accepted
2016-11-14 07:51:50
Documents
39
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q proteo_10q-093016.htm 10-Q 181298
2 CERTIFICATION proteo_10q-ex3101.htm EX-31.1 9334
3 CERTIFICATION proteo_10q-ex3102.htm EX-31.2 9447
4 CERTIFICATION proteo_10q-ex32.htm EX-32 5416
  Complete submission text file 0001683168-16-000562.txt   1056602

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pteo-20160930.xml EX-101.INS 99883
6 XBRL SCHEMA FILE pteo-20160930.xsd EX-101.SCH 13657
7 XBRL CALCULATION FILE pteo-20160930_cal.xml EX-101.CAL 29483
8 XBRL DEFINITION FILE pteo-20160930_def.xml EX-101.DEF 40208
9 XBRL LABEL FILE pteo-20160930_lab.xml EX-101.LAB 92876
10 XBRL PRESENTATION FILE pteo-20160930_pre.xml EX-101.PRE 79077
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

IRS No.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 161990615
SIC: 2834 Pharmaceutical Preparations